Signaling Pathways
A basic property of living systems is the ability to respond to extracellular signals by evoking an internal response. Signal-transduction cascades mediate the sensing and processing of these stimuli. These molecular circuits detect, amplify, and integrate diverse external signals to generate responses such as changes in enzyme activity, gene expression, phenotypic alterations, or ion-channel activity. Signal-transduction pathways follow a broadly similar course that can be viewed as a molecular circuit. Upon an environmental signal, Membrane receptors transfer information from the environment to the cell's interior. Subsequently, second messengers relay information from the receptor-ligand complex into the cell's interior. Particularly important second messengers include cyclic AMP and cyclic GMP, calcium ion, inositol 1,4,5-trisphosphate, (IP3), and diacylglycerol. While these second messengers are free to move, they can easily diffuse to other compartments of the cell, such as the nucleus, where they can influence gene expression and other processes. Interestingly, signal transduction may be amplified significantly in the generation of second messengers, since initial stimulation may lead to the generation of many second messengers within the cell. Thus, a low concentration of signal in the environment, even as little as a single molecule, can yield a large intracellular signal and response. Besides this phenomenon, cross-talk between two or more signaling cascades may occur, which permits more finely tuned regulation of cell activity than would the action of individual independent pathways[1]
[1] Signal-Transduction Pathways: An Introduction to Information Metabolism. Biochemistry. 5th edition. J.M. Berg, J.L.Tymoczko, L. Stryer.New York, 2002.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
1687 | (±)-E-Homocamptothecin | Potent topoisomerase I (Topo 1) inhibitor | €120.00 | |
2537 | 1,5-Isoquinolinediol | PARP1 inhibitor and neuroprotective agent | €50.00 | |
2222 | 10058-F4 | c-Myc inhibitor inducing cell-cycle arrest at G0/G1 phase | €80.00 | |
1496 | 3-Aminobenzamide | Competitive small molecule inhibitor of PARP | €40.00 | |
1529 | AG 014699 | PARP1 inhibitor | €60.00 | |
3834 | Alantolactone | STAT3 inhibitor; NLRP3 inhibitor | €90.00 | |
3008 | AOH1160 | First-in-class, potent and orally available PCNA inhibitor | €120.00 | |
4030 | AOH1996 | Orally available PCNA inhibitor | €140.00 | |
3220 | ARN24139 | Orally active topoisomerase II poison | €130.00 | |
1992 | AS 1517499 | Potent and selective STAT6 inhibitor | €130.00 | |
2839 | AS 1842856 | Inhibitor of the Forkhead box protein O1 (FOXO1) | €95.00 | |
4140 | AZD0156 | Selective and orally active ATM inhibitor | €90.00 | |
2241 | AZD2461 | PARP inhibitor with poor P-glycoprotein substrate qualities | €95.00 | |
4068 | AZD7648 | DNA-PK inhibitor | €90.00 | |
1399 | AZD7762 hydrochloride | CHK inhibitor | €60.00 | |
3760 | Belzutifan | Second-generation potent, selective and orally active HIF-2α inhibitor | €280.00 | |
4028 | BI-87G3 | Highly potent covalent NPAS3 heterodimer inhibitor | €120.00 | |
2301 | BIBR 1532 | Potent and selective telomerase inhibitor inducing senescence in human cancer cells. | €70.00 | |
2462 | BMH 21 | Inhibitor of RNA Polymerase I (RNAP1) | €95.00 | |
3786 | BP-1-102 | Orally bioavailable STAT3 inhibitor | €90.00 | |
3664 | Brivudine | Inhibitor of herpes virus DNA polymerase | €90.00 | |
3394 | CADD522 | Potent inhibitor of RUNX2-DNA binding | €90.00 | |
2699 | CCT251236 | HSF1 stress pathway inhibitor | €130.00 | |
1611 | CGP 57380 | Mnk1 inhibitor | €95.00 | |
1636 | CHIR124 | CHK1 inhibitor | €60.00 | |
3224 | CLK8 | CLOCK/BMAL1 interaction inhibitor | €150.00 | |
2841 | COTI-2 | Reactivator of mutant p53 | €125.00 | |
1495 | CP 466722 | ATM inhibitor | €70.00 | |
2391 | CS1 | TOPO IIα inhibitor with broad-spectrum in vitro antitumor effects | €135.00 | |
2455 | CU-T12-9 | Selective TLR1/TLR2 agonist that facilitates the TLR1/2 complex formation | €120.00 |